Ritonavir Recruiting Phase 2 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02542852A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia